ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Publisher, Law Firm Settle Suit Over Newsletter Photocopy

November 15, 1991

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

NCI-Frederick Leases Office Building To Move Some Programs Off Army Base.

February 26, 2010

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

December 15, 2000